# Midazolam With Meperidine and Dexmedetomidine vs. Midazolam With Meperidine and Propofol for Sedation During ERCP

> **NCT02475824** · PHASE4 · COMPLETED · sponsor: **Dankook University** · enrollment: 258 (actual)

## Conditions studied

- Complication

## Interventions

- **DRUG:** Midazolam®
- **DRUG:** "Meperidine" (pethidine®)
- **DRUG:** Propofol®
- **DRUG:** Dexmedetomidine (Precedex®)

## Key facts

- **NCT ID:** NCT02475824
- **Lead sponsor:** Dankook University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-11-30
- **Final completion:** 2017-01-30
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2018-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02475824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02475824, "Midazolam With Meperidine and Dexmedetomidine vs. Midazolam With Meperidine and Propofol for Sedation During ERCP". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02475824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*